JPRN-jRCT2080220862未知2 期
DD-723 Phase II clinical trial - Dose-response study in patients with suspected prostate cancer
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 75 人开始时间: 2009年9月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- Male
入选标准
- •Patients with suspected prostate cancer
- •- Patients whose most recent PSA level is between 4.0 ng/mL and 20 ng/mL
- •- Patients aged between 20 and 80 years at the time of informed consent
排除标准
- •- Items listed on the package insert (including absolute contraindications, careful administration, and precautions) to ensure safety.
- •- Items related to safety and ethics
- •- Items related to surgery, procedures, and treatment that are considered to influence efficacy and safety assessment for this drug
研究者
相似试验
未知
2 期
DD-723 Phase II clinical trial (Breast)Patients with breast tumorJPRN-jRCT2080220863DAIICHISANKYO Co.,Ltd.75
未知
1 期
Phase I Clinical Trial of DS-7423JPRN-jRCT2080221724DAIICHISANKYO Co.,Ltd.27
未知
3 期
DD-723 Phase III Clinical Trial (Prostate)Subjects with suspected prostate cancerJPRN-jRCT2080221271DAIICHISANKYO Co.,Ltd.120
未知
3 期
DD-723 Phase III Clinical Trial (Breast)JPRN-jRCT2080221250DAIICHISANKYO Co.,Ltd.120
未知
2 期
DS-7113b phase II studyModerate to severe cancer painJPRN-jRCT2080222120DAIICHISANKYO Co.,Ltd.